CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.
CANbridge Pharmaceuticals Inc. has announced its upcoming virtual Annual General Meeting (AGM) to be held on June 27, 2024, where shareholders will vote on key resolutions including the re-election of executive and non-executive directors, the re-appointment of Ernst & Young as the company’s auditor, and the approval of share allocation powers to the directors. The proposed resolutions could impact the company’s share capital and future financial strategies. This meeting is pivotal for shareholders and potential investors as the decisions made may significantly influence the company’s direction and stock performance.
For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.
